Luther King Capital Management (LKCM)’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,626
| Closed | -$427K | – | 607 |
|
|
2024
Q2 | $427K | Sell |
4,626
-348
| -7% | -$32.1K | ﹤0.01% | 484 |
|
|
2024
Q1 | $475K | Sell |
4,974
-470
| -9% | -$44.9K | ﹤0.01% | 474 |
|
|
2023
Q4 | $415K | Sell |
5,444
-242
| -4% | -$18.5K | ﹤0.01% | 479 |
|
|
2023
Q3 | $394K | Sell |
5,686
-2,140
| -27% | -$148K | ﹤0.01% | 484 |
|
|
2023
Q2 | $738K | Sell |
7,826
-1,631
| -17% | -$154K | ﹤0.01% | 431 |
|
|
2023
Q1 | $782K | Sell |
9,457
-874
| -8% | -$72.3K | ﹤0.01% | 415 |
|
|
2022
Q4 | $771K | Hold |
10,331
| – | – | ﹤0.01% | 408 |
|
|
2022
Q3 | $854K | Sell |
10,331
-976
| -9% | -$80.7K | 0.01% | 390 |
|
|
2022
Q2 | $1.08M | Buy |
11,307
+480
| +4% | +$45.6K | 0.01% | 380 |
|
|
2022
Q1 | $1.28M | Buy |
10,827
+74
| +0.7% | +$8.71K | 0.01% | 368 |
|
|
2021
Q4 | $1.39M | Sell |
10,753
-295
| -3% | -$38.2K | 0.01% | 361 |
|
|
2021
Q3 | $1.25M | Sell |
11,048
-528
| -5% | -$59.8K | 0.01% | 380 |
|
|
2021
Q2 | $1.2M | Sell |
11,576
-52
| -0.4% | -$5.39K | 0.01% | 395 |
|
|
2021
Q1 | $973K | Sell |
11,628
-587
| -5% | -$49.1K | 0.01% | 391 |
|
|
2020
Q4 | $1.11M | Sell |
12,215
-396
| -3% | -$36.1K | 0.01% | 360 |
|
|
2020
Q3 | $1.01M | Buy |
12,611
+6,314
| +100% | +$504K | 0.01% | 329 |
|
|
2020
Q2 | $435K | Buy |
6,297
+573
| +10% | +$39.6K | ﹤0.01% | 412 |
|
|
2020
Q1 | $360K | Sell |
5,724
-4,785
| -46% | -$301K | ﹤0.01% | 413 |
|
|
2019
Q4 | $817K | Buy |
10,509
+4,215
| +67% | +$328K | 0.01% | 366 |
|
|
2019
Q3 | $461K | Buy |
+6,294
| New | +$461K | ﹤0.01% | 420 |
|